Skip to content

2019-nCoV Outbreak and Cardiovascular Diseases

Impact of a Novel Coronavirus (2019-nCoV) Outbreak on Public Anxiety and Cardiovascular Disease Risk in China

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04255940
Enrollment
12000
Registered
2020-02-05
Start date
2020-01-20
Completion date
2020-04-30
Last updated
2020-02-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cardiovascular Death; Major Adverse Cardiovascular Events

Brief summary

Cardiovascular events occurring after 2019-nCoV outbreak in Jinan were prospectively assessed by emergency physicians. We compared those events with events that occurred during the past 3 months and the same months of the last year.

Detailed description

This survey aims to assess whether the public anxiety from a novel coronavirus (2019-nCoV) outbreak increases cardiovascular disease risk in China. Cardiovascular events occurring after 2019-nCoV outbreak in Jinan were prospectively assessed by emergency physicians. We compared those events with events that occurred during the past 3 months and the same months of the last year.

Interventions

None listed

Sponsors

Qilu Hospital of Shandong University
Lead SponsorOTHER

Study design

Observational model
CASE_ONLY
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

* Patients visiting emergency department.

Exclusion criteria

\-

Design outcomes

Primary

MeasureTime frame
Cardiovascular Death3 months

Secondary

MeasureTime frame
Major Adverse Cardiovascular Events3 months
Times From symptom onset to hospital arrival3 months
Anxiety3 months

Countries

China

Contacts

Primary ContactPanpan Hao, MD
panda.how@sdu.edu.cn86-18560086593

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026